These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34216672)

  • 1. Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA.
    Liu E; Zhao S; Li X; Meng X; Liu B
    Int J Biol Macromol; 2021 Aug; 185():782-791. PubMed ID: 34216672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication, characterization and properties of DHA-loaded nanoparticles based on zein and PLGA.
    Liu E; Su Z; Yang C; Ji Y; Liu B; Meng X
    Food Chem; 2021 Oct; 360():129957. PubMed ID: 33989879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
    Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery.
    Amin MK; Boateng JS
    Ther Deliv; 2019 Aug; 10(8):493-514. PubMed ID: 31496377
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
    Luo Y; Zhang B; Whent M; Yu LL; Wang Q
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol.
    Miele D; Catenacci L; Sorrenti M; Rossi S; Sandri G; Malavasi L; Dacarro G; Ferrari F; Bonferoni MC
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.
    Tada DB; Singh S; Nagesha D; Jost E; Levy CO; Gultepe E; Cormack R; Makrigiorgos GM; Sridhar S
    Pharm Res; 2010 Aug; 27(8):1738-45. PubMed ID: 20521086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation, characterization and application of arginine-modified chitosan/γ-poly glutamic acid nanoparticles as carrier for curcumin.
    Su Z; Han C; Liu E; Zhang F; Liu B; Meng X
    Int J Biol Macromol; 2021 Jan; 168():215-222. PubMed ID: 33309665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of chitosan modified poly lactic co-glycolic acid biodegradable nanoparticles following oral delivery of gentamicin in rabbits.
    Akhtar B; Muhammad F; Aslam B; Saleemi MK; Sharif A
    Int J Biol Macromol; 2020 Dec; 164():1493-1500. PubMed ID: 32735923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.
    Liu C; Zhang S; McClements DJ; Wang D; Xu Y
    J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
    Wang Y; Li P; Kong L
    AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
    Lee SY; Koo JS; Yang M; Cho HJ
    J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
    Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
    Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.